You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is All of the following are false about Tenapanor except: and explain in detail?
Tenapanor Small molecule medication approved in September 2019 for the treatment of constipation-predominant irritable bowel-syndrome (IBS-C). MOA - Inhibitor of the sodium/hydrogen exchanger isoform 3 (NHE3) transpoer First and currently only medication within its class By inhibiting NHE3 on the apical surface of the enterocytes, tenapanor reduces absorption of sodium from the small intestine and colon, Resulting in an increase in water secretion into the intestinal lumen, which accelerates intestinal transit time and results in a softer stool consistency. Recommended dosage in adults - 50 mg orally twice daily- prior to breakfast or the first meal of the day and immediately prior to dinner C/I Patients< 6 years of age due to the risk of serious dehydration, Patients with known or suspected mechanical gastrointestinal obstruction